ANZATAX
PACLITAXEL
Public price
619,00 MAD
Active substance
PACLITAXEL
Laboratory
PFIZER
Reimbursable
What is this medicine?
A microtubule inhibitor formulated as protein-bound particles for injectable suspension (albumin-bound) for intravenous use.
Verified summary
PACLITAXEL, SOLUTION A DILUER POUR PERFUSION, 30 MG / 5 ML, FLACON DE 5 ML
Common uses
Metastatic breast cancer,Locally advanced or metastatic non-small cell lung cancer (NSCLC),Metastatic adenocarcinoma of the pancreas
Class
Microtubule inhibitor
Laboratory
PFIZER
Availability note
Reimbursable
Hospital price
411,00 MAD
Strength
30 MG / 5 ML
Form
SOLUTION A DILUER POUR PERFUSION
Presentation
FLACON DE 5 ML
Commercial status
Retiré du Marché
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: 619,00 MAD
Available presentations and strengths
Medicines with the same active substance
PACLI SPAL-L 100
100 MG / 16,7 ML · BOITE DE 1 FLACON UNIDOSE DE 20 ML
1,08 MAD
PACLITAXEL KABI
6 MG / ML · FLACON DE 16,7 ML
1,08 MAD
EBETAXEL
100 MG / 16,7 ML · FLACON DE 16,7 ML
1,11 MAD
OKA-PACLITAXEL
100 MG / 16,7 ML · BOITE DE 1 FLACON DE 20 ML
1,11 MAD
PACLITAXEL COOPER
100 MG / 16,7 ML · BOITE DE 1
1,11 MAD
PACLITAXEL ISIO
100 MG / 16,7 ML · BOITE D'UN FLACON
1,11 MAD
PACLITAXEL PHARMACHEMIE
6 MG / ML · FLACON DE 150 MG / 25 ML
1,34 MAD
PACLITAXEL MYLANPHARMA
300 MG / 50 ML · 0
1,57 MAD
PACLITAXEL MC PHARMA
6 MG / ML · FLACON DE 50 ML
1,59 MAD
EBETAXEL
300 MG / 50 ML · FLACON 50ML
2,07 MAD
PACLI SPAL-L 300
300 MG / 50 ML · BOITE DE 1 FLACON UNIDOSE DE 50 ML
2,07 MAD
PACLITAXEL KABI
6 MG / ML · FLACON DE 50 ML
2,07 MAD